We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

If I’d invested £1,000 in AstraZeneca shares five years ago, here’s what I’d have now

AstraZeneca shares have been the FTSE 100’s standout star over the past five years. But how much would I have made buying this stock five years ago?

| More on:
Engineer Project Manager Talks With Scientist working on Computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At present, the total value of the UK’s FTSE 100 index is almost £2.03trn. Yet just 10 mega-cap firms account for £1trn (49.1%) of this total. The biggest Footsie company today is pharmaceutical giant AstraZeneca (LSE: AZN), whose shares have soared in recent years.

XXX

The rise and rise of AstraZeneca shares

On Friday, the AstraZeneca share price closed at 11,746p, down 50p. This values the UK’s biggest healthcare company at £180.8bn. Therefore, this business alone accounts for 8.9% of the entire FTSE 100.

Why is AstraZeneca worth so much? Because its shares have been surging for years. Here’s how the share price has performed over eight periods:

One week-2.2%
One month+5.2%
Three months+10.4%
Six months+16.0%
One year+11.2%
Two years+56.5%
Three years+43.5%
Five years+135.3%

Remarkably, the stock has produced positive returns over all periods ranging from one month to five years. The only fall was a modest decline last week.

Thanks to this outstanding performance, the shares have thrashed the FTSE 100 (+4%) over the past half-decade. In fact, this stock is the Footsie’s #1 performer over the last five years.

However, the above returns exclude cash dividends, which would add a few percentage points a year to these figures.

Investing £1,000 five years ago

To answer the question in my title: how much would I have today had I bought £1,000 of AstraZeneca stock exactly five years ago?

The shares’ 135.3% capital gain over 60 months would have turned my original £1,000 into £2,353 today. That works out at a compound annual growth rate of 18.7% a year. Nice.

However, AstraZeneca shares pay out regular dividends in US dollars. Here are the last five years’ payouts:

Financial year-endTotal dividendsIn £s today
31/12/2022$2.90£2.31
31/12/2021$2.87£2.29
31/12/2020$2.80£2.23
31/12/2019$2.80£2.23
31/12/2018$2.80£2.23
Total$14.17£11.30

My table shows total dividends per share paid out over the past five years add up to £11.30.

The original £1,000 investment would have bought 20 AstraZeneca shares at just under £50 each in 2018. Thus, my total dividends would come to £11.30 times 20, which is £225.90.

Hence, my total return (capital gain plus cash dividends) from AstraZeneca stock over five years would be £2,353 plus £225.90, which equals £2,578.90.

That’s a total return of 157.9%, which works out at a compound annual growth rate of almost 20.9% a year. How I’d love to have earned similar returns from every stock in my portfolio.

What about the future?

Investors who jumped aboard the AstraZeneca bandwagon have seen the company’s revenues more than double over the past five years, leaping from $22.1bn in 2018 to $44.4bn in 2022.

Of course, there’s no guarantee that the rapid growth in both revenues and the share price will continue for another five years. But analysts highly rate CEO Pascal Soriot (appointed back in October 2012) and his leadership team.

That said, I wouldn’t buy the stock today. This is only because my wife and I already have large sums invested in FTSE 100 index trackers. And remember that AstraZeneca accounts for almost 9% of the entire Footsie. Hence, my family already has a decent stake in this great British business!

Cliff D'Arcy has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services, such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool, we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »